Cargando…

The molecular mechanisms underlying the ERα-36-mediated signaling in breast cancer

Alterations in estrogen-mediated cellular signaling have largely been implicated in the pathogenesis of breast cancer. Here, we investigated the signaling regulation of a splice variant of the estrogen receptor, namely estrogen receptor (ERα-36), associated with a poor prognosis in breast cancers. C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omarjee, S, Jacquemetton, J, Poulard, C, Rochel, N, Dejaegere, A, Chebaro, Y, Treilleux, I, Marangoni, E, Corbo, L, Romancer, M Le
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422711/ https://www.ncbi.nlm.nih.gov/pubmed/27941878 http://dx.doi.org/10.1038/onc.2016.415

Ejemplares similares

ERα-36 regulates progesterone receptor activity in breast cancer
por: Konan, Henri-Philippe, et al.
Publicado: (2020)

Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα (+) breast cancer
por: Poulard, Coralie, et al.
Publicado: (2023)

The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer
por: Choucair, Ali, et al.
Publicado: (2019)

Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer
por: Poulard, Coralie, et al.
Publicado: (2019)

Role of JMJD6 in Breast Tumourigenesis
por: Poulard, Coralie, et al.
Publicado: (2015)

JMJD6 Regulates ERα Methylation on Arginine
por: Poulard, Coralie, et al.
Publicado: (2014)

PRMT1, a Key Modulator of Unliganded Progesterone Receptor Signaling in Breast Cancer
por: Malbeteau, Lucie, et al.
Publicado: (2022)

Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes
por: Teinturier, Romain, et al.
Publicado: (2021)

The Role of ERα36 in Development and Tumor Malignancy
por: Thiebaut, Charlène, et al.
Publicado: (2020)

Phosphorylation of the Retinoic Acid Receptor Alpha Induces a Mechanical Allosteric Regulation and Changes in Internal Dynamics
por: Chebaro, Yassmine, et al.
Publicado: (2013)

Targeting AKT in ER-Positive HER2-Negative Metastatic Breast Cancer: From Molecular Promises to Real Life Pitfalls?
por: Mery, Benoîte, et al.
Publicado: (2021)

Activation of rapid oestrogen signalling in aggressive human breast cancers
por: Poulard, Coralie, et al.
Publicado: (2012)

Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant
por: Jacquemetton, Julien, et al.
Publicado: (2021)

Allosteric Regulation in the Ligand Binding Domain of Retinoic Acid Receptorγ
por: Chebaro, Yassmine, et al.
Publicado: (2017)

Protein arginine methylation/demethylation and cancer
por: Poulard, Coralie, et al.
Publicado: (2016)

PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer
por: Noureddine, Lara Malik, et al.
Publicado: (2023)

Novel interactions between ERα-36 and STAT3 mediate breast cancer cell migration
por: Xiang, Yuan, et al.
Publicado: (2019)

ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells
por: Deng, Hao, et al.
Publicado: (2014)

Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulation
por: Redmond, Aisling M., et al.
Publicado: (2019)

Deciphering of a Putative GPER Recognition Domain in ERα and ERα36
por: Acramel, Alexandre, et al.
Publicado: (2022)

Dual Epigenetic Regulation of ERα36 Expression in Breast Cancer Cells
por: Thiebaut, Charlène, et al.
Publicado: (2019)

Chaperone gp96 mediates ER-α36 cell membrane expression
por: Hou, Junwei, et al.
Publicado: (2015)

Huaier polysaccharide inhibits the stem-like characteristics of ERα-36(high) triple negative breast cancer cells via inactivation of the ERα-36 signaling pathway
por: Hu, Baoquan, et al.
Publicado: (2019)

From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression
por: Chamard-Jovenin, Clémence, et al.
Publicado: (2015)

ER-α36: a novel biomarker and potential therapeutic target in breast cancer
por: Su, Xingyun, et al.
Publicado: (2014)

Long-term exposure to bisphenol A or benzo(a)pyrene alters the fate of human mammary epithelial stem cells in response to BMP2 and BMP4, by pre-activating BMP signaling
por: Clément, Flora, et al.
Publicado: (2017)

PRMT1 Is Critical for the Transcriptional Activity and the Stability of the Progesterone Receptor
por: Malbeteau, Lucie, et al.
Publicado: (2020)

Enhancement of Sensitivity to Tamoxifen by Berberine in Breast Cancer Cells by Inhibiting ER-α36 Expression
por: Pan, Xiaohua, et al.
Publicado: (2022)

A Positive Feedback Loop of ER-α36/EGFR Promotes Malignant Growth of ER-negative Breast Cancer Cells
por: Zhang, XianTian, et al.
Publicado: (2010)

ER-α36-mediated gastric cancer cell proliferation via the c-Src pathway
por: WANG, XUMING, et al.
Publicado: (2013)

ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway
por: Zhu, Linlin, et al.
Publicado: (2018)

The essential role of YAP in ERα36-mediated proliferation and the epithelial-mesenchymal transition in MCF-7 breast cancer cells
por: Park, Miso, et al.
Publicado: (2022)

ER-α36, a Novel Variant of ER-α, Mediates Estrogen-Stimulated Proliferation of Endometrial Carcinoma Cells via the PKCδ/ERK Pathway
por: Tong, Jing-Shan, et al.
Publicado: (2010)

ERα36-High Cancer-Associated Fibroblasts as an Unfavorable Factor in Triple-Negative Breast Cancer
por: Nagel, Anna, et al.
Publicado: (2022)

Involvement of the Akt signaling pathway in ER-α36/GRP94-mediated signaling in gastric cancer
por: FU, ZHENGQI, et al.
Publicado: (2014)

ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2
por: Wang, Chunyan, et al.
Publicado: (2021)

The Asymmetric Binding of PGC-1α to the ERRα and ERRγ Nuclear Receptor Homodimers Involves a Similar Recognition Mechanism
por: Takacs, Maria, et al.
Publicado: (2013)

Estrogen Receptor-Alpha 36 Mediates Mitogenic Antiestrogen Signaling in ER-Negative Breast Cancer Cells
por: Zhang, XinTian, et al.
Publicado: (2012)

Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer
por: Noureddine, Lara Malik, et al.
Publicado: (2021)

Proximal Protein Interaction Landscape of RAS Paralogs
por: Béganton, Benoît, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nfh673l250f46ot1knjchgpbp6